Closing Bell: Cardiol Therapeutics Inc down on Wednesday (CRDL)

In today's trading, Cardiol Therapeutics Inc stock opened at $2.79 and closed at $2.62. Intraday prices ranged from $2.60 to $2.79.

Shares dipped -5.42% from the previous day's close of $2.77.

Today across North America, the TSX Composite closed -0.45% at 21880.95, the S&P 500 closed -0.77% at 5199.50, the Dow Jones Industrial Average closed -0.60% at 38763.45 and the Nasdaq Composite closed 1.03% at 16366.85.

Cardiol Therapeutics Inc traded under CRDL on the Toronto Stock Exchange (TSX).

A total of 115,853 shares was traded during the session, with total trades of 306. On average, Cardiol Therapeutics Inc has traded 117,110 shares over the last 5-days and 148,819 year-to-date.

Trading across the entire TSX saw 1,858 price advancers against 3,319 declines and 108 unchanged.

During the prior 52 weeks, CRDL.TO has traded as high as $4.26 (June 12,2024) and low as $0.91 (October 23,2023). Moreover, in the last 52 weeks, Cardiol Therapeutics Inc's shares have soared 63.75%, while they have risen 138.18% this year.

Following today's trading, Cardiol Therapeutics Inc has a market capitalization of $192.21 million on a float of 69,391 shares outstanding. Its annual EPS is $-0.47.

Cardiol Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Oakville, CAN.

Currently, Cardiol Therapeutics Inc's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..